Search Within

Martee L Hensley

Formats
  1. Journal Article (174)
  2. Meeting Abstract (106)
  3. Book Section (7)
  4. Correspondence (1)
  5. Editorial (1)
  6. Guidelines (1)
Groups
  1. Department of Medicine (290)
  2. GDMT, Medicine (290)
  3. Gynecologic Medicine Service (290)
  4. Gynecology Disease Management Team (290)
  5. Solid Tumor Oncology Division (290)
  6. Surgery (129)

More Groups

People
  1. Carol Aghajanian (94)
  2. Paul Sabbatini (81)
  3. Robert Soslow (63)
  4. David Spriggs (55)
  5. Mario Leitao (53)
  6. Richard Barakat (53)

More People

Years
  1. 2025 (3)
  2. 2024 (9)
  3. 2023 (11)
  4. 2022 (16)
  5. 2021 (6)
  6. 2020 (10)

More Years

Publications
  1. Journal of Clinical Oncology (80)
  2. Gynecologic Oncology (73)
  3. International Journal of Gynecological Cancer (22)
  4. Modern Pathology (18)
  5. Clinical Cancer Research (15)
  6. Laboratory Investigation (11)

More Publications

Publishers
  1. American Society of Clinical Oncology (83)
  2. Elsevier B.V. (75)
  3. Lippincott Williams & Wilkins (33)
  4. Nature Research (18)
  5. American Association for Cancer Research (17)
  6. Nature Publishing Group (13)

More Publishers

Results (290)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immunohistochemical expression of estrogen and progesterone receptors and outcomes in patients with newly diagnosed uterine leiomyosarcoma
    Journal Article

    Leitao, M. M. Jr; Hensley, M. L.; Barakat, R. R.; Aghajanian, C.; Gardner, G. J.; Jewell, E. L.; O'cearbhaill, R.; Soslow, R. A.
    Gynecologic Oncology (2012)

    Fulltext@MSK | Save
  • A phase II evaluation of trabectedin in the treatment of advanced, persistent, or recurrent uterine leiomyosarcoma: A gynecologic oncology group study
    Journal Article

    Monk, B. J.; Blessing, J. A.; Street, D. G.; Muller, C. Y.; Burke, J. J.; Hensley, M. L.
    Gynecologic Oncology (2012)

    Fulltext@MSK | Save
  • Eribulin mesylate (halichondrin B analog E7389) in platinum-sensitive ovarian cancer: A phase II study, CTEP #7431
    Meeting Abstract

    Hensley, M. L.; Kravetz, S. J.; Jia, X.; Tew, W. P.; Pereira, L.; Sabbatini, P.; Whalen, C.; Aghajanian, C.; Zarwan, C.; Berlin, S. T.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • A phase II trial of sorafenib (S) and dacarbazine (D) in leiomyosarcoma (LMS), synovial sarcoma (SS), and malignant peripheral nerve sheath tumor (MPNST)
    Meeting Abstract

    D'Adamo, D. R.; Keohan, M. L.; Carvajal, R. D.; Hensley, M. L.; Hirst, C.; Qin, L.; Antonescu, C.; Lefkowitz, R. A.; Schwartz, G. K.; Maki, R. G.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase II study of intraperitoneal paclitaxel plus cisplatin and intravenous paclitaxel plus bevacizumab as adjuvant treatment of optimal stage II/III epithelial ovarian cancer
    Journal Article

    Konner, J. A.; Grabon, D. M.; Gerst, S. R.; Iasonos, A.; Thaler, H.; Pezzulli, S. D.; Sabbatini, P. J.; Bell-Mcguinn, K. M.; Tew, W. P.; Hensley, M. L.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Role of chemotherapy and biomolecular therapy in the treatment of uterine sarcomas
    Journal Article

    Hensley, M. L.
    Best Practice and Research: Clinical Obstetrics and Gynaecology (2011)

    Fulltext@MSK | Save
  • Low-grade leiomyosarcoma and late-recurring smooth muscle tumors of the uterus: A heterogenous collection of frequently misdiagnosed tumors associated with an overall favorable prognosis relative to conventional uterine leiomyosarcomas
    Journal Article

    Veras, E.; Zivanovic, O.; Jacks, L.; Chiappetta, D.; Hensley, M.; Soslow, R.
    American Journal of Surgical Pathology (2011)

    Fulltext@MSK | Save
  • Sentinel lymph node mapping for grade 1/2 endometrial cancer with superficial myoinvasion: Less is more
    Meeting Abstract

    Collado, F. K; Murray, M.; Hensley, M.; Sonoda, Y.; Gomez, J.; Levine, D.; Leitao, M.; Chi, D.; Barakat, R.; Abu Rustum, N.
    Gynecologic Oncology (2011)

    Fulltext@MSK | Save
  • The revised 2009 FIGO staging system for endometrial cancer: Should the 1988 FIGO stages IA and IB be altered?
    Journal Article

    Abu-Rustum, N. R.; Zhou, Q.; Iasonos, A.; Alektiar, K. M.; Leitao, M. M.; Chi, D. S.; Sonoda, Y.; Soslow, R.; Hensley, M.; Barakat, R. R.
    International Journal of Gynecological Cancer (2011)

    Fulltext@MSK | Save
  • Sentinel lymph node mapping for endometrial cancer improves the detection of metastatic disease to regional lymph nodes
    Journal Article

    Khoury-Collado, F.; Murray, M. P.; Hensley, M. L.; Sonoda, Y.; Alektiar, K. M.; Levine, D. A.; Leitao, M. M.; Chi, D. S.; Barakat, R. R.; Abu-Rustum, N. R.
    Gynecologic Oncology (2011)

    Fulltext@MSK | Save